AB DENTALAC™ and Pediococcus acidilactici patent granted in Mexico

 27 May 2021 – 1 min read

We are happy to announce the IP protection in Mexico for all Pediococcus acidilactici strains, including the P. acidilactici KABPTM 053 (CECT 8633).

This new patent covers the use of a P. acidilactici strain for treatment of any disorder in combination with at least one antiseptic.

P.acidilactici KABP TM 053 (CECT 8633) is included in the 3-strain probiotic formula AB-DENTALAC,  which have clinically demonstrated positive effects in patients oral health.

From now on,  AB-BIOTICS products sold in Mexico including P. acidilactici  will be able to indicate in their labels the identification code “Mexican Patent MX 379324” . 

Products will be able to indicate in their labels the identification code “Mexican Patent MX 379324”

AB-BIOTICS keeps putting all the efforts in the microbiome research beyond the gut, covering a wide range of therapeutic areas where microbiota has demonstrated to play a critical role in health and disease.

Authors: Mercè Mengual (Pharmacist)